Increasing Equity in Lung Cancer Screening
Launched by INDIANA UNIVERSITY · Apr 8, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Increasing Equity in Lung Cancer Screening," aims to improve lung cancer screening efforts, especially for patients visiting the emergency department. Researchers want to gather insights from key individuals involved, like patients and healthcare providers, to enhance a specific screening program. They will also test this program to see how well it works, how acceptable it is to patients, and whether it can be easily implemented.
To participate in this trial, individuals need to be between 50 and 80 years old, have a history of smoking within the last 15 years (with a significant amount of smoking, known as 20 pack years), and be eligible for lung cancer screening. People who do not speak English or Spanish, those with serious mental health issues, or individuals currently facing life-threatening conditions are not eligible. Participants will be asked questions about their experiences with the screening and will help researchers understand how to make it better for everyone. Overall, this study focuses on making lung cancer screening more accessible and effective for all patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years)
- Exclusion Criteria:
- • • Non-English/Spanish speaking
- • Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment
- • Intoxicated with alcohol or drugs
- • Cannot provide reliable follow up contact information (cell phone)
- • Presenting to the ED with a life-threatening condition
- • Have received chest CT scan in past 12 months
- • Already enrolled in LCS
- • Hospice enrolled
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported